Manulife (Manufacturers Life Insurance)’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$311K Sell
15,879
-523
-3% -$12.8K ﹤0.01% 2324
2025
Q4
$439K Sell
16,402
-1,360
-8% -$35K ﹤0.01% 2233
2025
Q3
$473K Sell
17,762
-926
-5% -$23.9K ﹤0.01% 2235
2025
Q2
$429K Sell
18,688
-1,138
-6% -$28.2K ﹤0.01% 2239
2025
Q1
$575K Sell
19,826
-1,431
-7% -$45.7K ﹤0.01% 2076
2024
Q4
$789K Sell
21,257
-610
-3% -$27.9K ﹤0.01% 2012
2024
Q3
$1.06M Sell
21,867
-379
-2% -$16.6K ﹤0.01% 1892
2024
Q2
$890K Buy
22,246
+954
+4% +$39.5K ﹤0.01% 1921
2024
Q1
$935K Buy
21,292
+1,641
+8% +$84.8K ﹤0.01% 1894
2023
Q4
$1.22M Sell
19,651
-431
-2% -$22.6K ﹤0.01% 1706
2023
Q3
$924K Buy
20,082
+4,381
+28% +$239K ﹤0.01% 1780
2023
Q2
$902K Buy
15,701
+141
+0.9% +$6.25K ﹤0.01% 1713
2023
Q1
$584K Buy
15,560
+69
+0.4% +$2.26K ﹤0.01% 1915
2022
Q4
$434K Sell
15,491
-110
-0.7% -$3.19K ﹤0.01% 2082
2022
Q3
$438K Buy
15,601
+61
+0.4% +$1.99K ﹤0.01% 2061
2022
Q2
$541K Buy
15,540
+114
+0.7% +$4.07K ﹤0.01% 2000
2022
Q1
$554K Sell
15,426
-4,216
-21% -$120K ﹤0.01% 2143
2021
Q4
$457 Sell
19,642
-794
-4% -$16.2K ﹤0.01% 2321
2021
Q3
$388K Sell
20,436
-1,259
-6% -$24.7K ﹤0.01% 2475
2021
Q2
$437K Buy
21,695
+62
+0.3% +$1.17K ﹤0.01% 2532
2021
Q1
$396K Sell
21,633
-408
-2% -$7.59K ﹤0.01% 2439
2020
Q4
$443K Buy
22,041
+343
+2% +$6.67K ﹤0.01% 2273
2020
Q3
$407K Hold
21,698
﹤0.01% 2102
2020
Q2
$480K Sell
21,698
-1,863
-8% -$34.1K ﹤0.01% 1985
2020
Q1
$350K Buy
23,561
+1,347
+6% +$23.4K ﹤0.01% 2007
2019
Q4
$429K Sell
22,214
-917
-4% -$17.6K ﹤0.01% 2139
2019
Q3
$468K Sell
23,131
-112
-0.5% -$2.33K ﹤0.01% 2056
2019
Q2
$491K Sell
23,243
-401
-2% -$8.38K ﹤0.01% 2061
2019
Q1
$483K Buy
23,644
+283
+1% +$6.34K ﹤0.01% 2103
2018
Q4
$465K Sell
23,361
-1,419
-6% -$28K ﹤0.01% 1999
2018
Q3
$477K Sell
24,780
-3,133
-11% -$55.8K ﹤0.01% 2331
2018
Q2
$427K Buy
27,913
+126
+0.5% +$2.2K ﹤0.01% 2511
2018
Q1
$521K Sell
27,787
-813
-3% -$15.3K ﹤0.01% 2300
2017
Q4
$550K Buy
28,600
+12
+0% +$224 ﹤0.01% 2254
2017
Q3
$510K Sell
28,588
-113
-0.4% -$1.86K ﹤0.01% 2257
2017
Q2
$512K Buy
28,701
+312
+1% +$4.95K ﹤0.01% 2269
2017
Q1
$412K Buy
28,389
+3,431
+14% +$54K ﹤0.01% 2326
2016
Q4
$459K Sell
24,958
-356
-1% -$6.93K ﹤0.01% 2157
2016
Q3
$480K Sell
25,314
-23
-0.1% -$417 ﹤0.01% 2114
2016
Q2
$408K Buy
25,337
+3,492
+16% +$49.3K ﹤0.01% 2168
2016
Q1
$261K Sell
21,845
-90
-0.4% -$1.06K ﹤0.01% 2405
2015
Q4
$312 Buy
21,935
+541
+3% +$7.15K ﹤0.01% 2333
2015
Q3
$250 Buy
21,394
+236
+1% +$3.54K ﹤0.01% 2469
2015
Q2
$372 Buy
21,158
+16,020
+312% +$250K ﹤0.01% 2332
2015
Q1
$77 Buy
5,138
+3,796
+283% +$50.7K ﹤0.01% 3243
2014
Q4
$16 Buy
1,342
+1,053
+364% +$11.5K ﹤0.01% 3397
2014
Q3
$3 Buy
+289
New +$3.01K ﹤0.01% 3699

Other funds holding AMPH

Manulife (Manufacturers Life Insurance)'s AMPH Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Amphastar Pharmaceuticals (AMPH) stake by 3.2% in Q1 2026, selling an estimated $12.8K and leaving 15,879 shares worth $311K. The position accounts for ﹤0.01% of the portfolio, ranked #2324.

Manulife (Manufacturers Life Insurance) first reported a position in AMPH in Q3 2014 and has held it in 47 quarters since. The position peaked at $1.22M in Q4 2023. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 15,879 shares of Amphastar Pharmaceuticals worth $311K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 523 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $12.8K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2324 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Amphastar Pharmaceuticals in Q3 2014 and has held it in 47 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Amphastar Pharmaceuticals position peaked at $1.22M in Q4 2023.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.